Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement - Wikidata - awgldk - TriplyDB

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

http://www.wikidata.org/entity/Q28174756

about

sameAs

Resistance to antiplatelet drugs: current status and future research The thienopyridines Clopidogrel in acute coronary heart disease Aspirin and clopidogrel resistance: an emerging clinical entity High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention Aspirin and clopidogrel resistance: consideration and management Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura Oral antiplatelet therapy and percutaneous coronary intervention Optimizing platelet P2Y12 inhibition for patients undergoing PCI Clopidogrel in the treatment of ischaemic heart disease Clopidogrel: an updated and comprehensive review Contemporary issues in clopidogrel therapy: new evidence shaping clinical practice Clopidogrel: the data, the experience, and the controversies.Safety and Efficacy of Intravenous Tirofiban as Antiplatelet Premedication for Stent-Assisted Coiling in Acutely Ruptured Intracranial Aneurysms.Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents.Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis.Clopidogrel "resistance": where are we now?Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antiplatelet treatment for coronary heart disease.Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention.Development of glycoprotein IIb-IIIa antagonists: translation of pharmacodynamic effects into clinical benefit.Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.High-dose clopidogrel loading in percutaneous coronary intervention.The benefits of abciximab questioned in percutaneous coronary interventions following pretreatment with high-dose clopidogrel.Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals.Clopidogrel resistance--the cardiologist's perspective.Myocardial infarction: contemporary management strategies.Aspirin and clopidogrel response variability: review of the published literature Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.Drug evaluation of clopidogrel in patients with ischemic stroke.Balancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome.Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes.

P2860

Q28192298-57E18A53-F8F4-4B81-9A15-D6990240B5E7 Q28193168-FF4D91D1-5605-4D6F-862B-75C1F097B116 Q28193776-C6308374-E969-43DA-9341-A0E4653E92C9 Q28194021-E9749F4C-BD52-4FA4-97B7-AB59EC2D436C Q28194081-AC696220-B294-4483-82D8-384553590AE5 Q28196661-8881C0B8-B81B-4574-ADD2-65614F6F5C1A Q28199817-84326FB3-26BC-4667-80D3-705F36CB4573 Q28200610-960FFE37-1CF6-4F07-9257-BB0B9E9163C6 Q28213393-4D35C800-22D1-4420-BAA8-BB15DB4AF66C Q28217724-8D8068AC-0778-4624-ACD2-B7500C964C81 Q28218094-F6DEEAD2-917A-4CFA-9B8D-EA78C42F063C Q28218576-30BA9FC8-98EA-4126-8D9E-EA37566910F4 Q28219411-97DFD610-54AA-4831-80C0-41994B078A22 Q28221366-D34386AA-6C7E-43D1-AA19-8FF8656E3457 Q30573045-A1B505ED-DD3A-4012-A2CC-2AB7FDFFBC03 Q33426776-14891093-EA08-4EC1-BB72-31F85513A79C Q33789829-56763BA1-1DF7-4976-A614-9D88BA64E8F2 Q33934090-52AC9F1B-648C-4B14-B1EC-7CC68F32EDC3 Q34212563-B52F2115-389B-49E0-890B-77E1D0F33FE5 Q34536091-E21DC69C-ECBC-4C83-8FA7-32D30B4DE57B Q34726838-17C89BAE-9779-4F12-9F91-0A9BFF06D3D0 Q34771381-25E98E0C-7AF7-4862-9026-99496646FAF7 Q35582491-48125774-6533-4489-9B21-F4519B4D20CC Q35584682-F5E4A568-86F9-451A-B4EE-C6ABE2857373 Q35752584-0EDFA88E-B35F-4E55-BFE7-3823BB2AA6D3 Q35773210-5D4CDBB3-7D53-415E-826D-B10C7B8097EC Q35808289-FEFC8579-EE56-48C0-BB24-0C878C5CEB40 Q35925710-2F1A70CE-FD31-46F7-914A-CA2D8EB3B5B4 Q36040667-7207C735-7DAF-47B5-913C-F37FCCD692A6 Q36089932-18D41C16-6167-4962-88F2-F867786C83EA Q36099433-6B1DB5C1-5711-4A29-B619-F2BD890AB4EE Q36213440-011FC239-EBD8-43B0-92B7-8D1698ABEB5F Q36634214-E655867B-F287-43E5-9E07-3893ADE26B4C Q36819608-943888F1-E6D8-4D97-A2DD-B9E078B699E3 Q36863859-0F7B974A-460B-4F3B-A674-80778A52AB19 Q36932221-CABB4A3A-C606-426E-A74A-2CE56D3D8402 Q36941850-3FC49E37-80D4-4E1C-9493-F6DAB31CE945 Q36979338-C619BE6F-8DC6-402A-9C68-B6A08A50FE05 Q37311337-07A459CD-1854-42C1-ADF2-C955821E7C78 Q37368786-605F0E00-299E-40D4-85E4-92112C848CB7

P2860

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

http://www.wikidata.org/entity/Q28174756

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Effect of a high loading dose ...... going coronary stent placement

@ast

Effect of a high loading dose ...... going coronary stent placement

@en

Effect of a high loading dose ...... going coronary stent placement

@nl

type

label

Effect of a high loading dose ...... going coronary stent placement

@ast

Effect of a high loading dose ...... going coronary stent placement

@en

Effect of a high loading dose ...... going coronary stent placement

@nl

prefLabel

Effect of a high loading dose ...... going coronary stent placement

@ast

Effect of a high loading dose ...... going coronary stent placement

@en

Effect of a high loading dose ...... going coronary stent placement

@nl

P1433

Q28174756-A5519148-0684-4BF9-B730-2CDA4AB1A001

P1476

Q28174756-DA2BE081-72C1-47DE-B3B9-68E1DB62B7C4

P2093

Q28174756-01AFEBCF-C506-4F1B-BB2C-212ED4D4341E

Q28174756-907049B3-2E21-4B25-9C99-28C0428CBE09

Q28174756-A2BD2C15-52FF-4135-817F-375261528CB3

Q28174756-CC565FC9-8CEE-4868-8876-B65997D23D91

Q28174756-CE9011EE-1BA2-4462-83AB-3D22A5D4030A

Q28174756-CF9C4CC8-807B-48B7-9038-3E7FF84E1D8F

Q28174756-E1829336-0093-4168-8A2D-B86D128961B7

P2860

Q28174756-0784A0F4-7533-49E1-B496-9B25048A84BA

Q28174756-309387B8-C1E9-4AC3-BEB7-CAA7F0561BDC

Q28174756-4DFAFF88-F8C1-4BDF-948C-49A167A5C6F0

Q28174756-57FE0860-C0A8-43ED-9BAF-F6266B9E72EF

Q28174756-6094148B-4CEA-4BE0-8E25-24585145C6FF

Q28174756-614A19E7-B1B5-4A97-AB84-06650158723C

Q28174756-6CD02F70-3772-4F8E-B2F1-5AF940063667

Q28174756-9DFE8F04-18A1-4F81-8A87-8442C18EFAAB

Q28174756-A370420D-A77B-4A7F-952B-D00F1E42E598

Q28174756-BE31D1CE-5F90-4617-8E08-A14676C183A4

P304

Q28174756-476C67F7-157F-4679-BB44-FD962115B6CE

P31

Q28174756-29754DD6-417D-413A-9A06-7ACD1FF031CC

P3181

Q28174756-284E11E2-029D-4407-899B-37A138AAD939

P356

Q28174756-B0C84E86-6939-404E-A489-BA46080D6D35

P407

Q28174756-9764C970-CB9D-4C4B-94B4-690451336531

P433

Q28174756-ACC0FF0E-3D6B-4D4B-906F-BBA6580AFC16

P478

Q28174756-7CA635D6-F002-41A0-9F43-FBCC47D56EC6

P577

Q28174756-E9C79541-ED84-42B1-A879-C68473CED17A

P5875

Q28174756-36459E85-55C4-49F6-9DE5-ABBF177D2183

P698

Q28174756-40C8E110-F351-40C3-9FEC-F36BC0F316D5

P921

Q28174756-B3EE67B8-6A44-4252-9320-60B831D7F636

Q28174756-EF0EB83C-5E58-4D6E-8628-15B7C1053A52

P932

Q28174756-F471B78A-3E98-47AD-BCFE-3D6CDBC6B67A

P3181

P356

P1433

P1476

Effect of a high loading dose ...... going coronary stent placement

@en

P2093

A Schömig

http://www.w3.org/2001/XMLSchema#string

B Wolf

http://www.w3.org/2001/XMLSchema#string

G Pogatsa-Murray

http://www.w3.org/2001/XMLSchema#string

I Müller

http://www.w3.org/2001/XMLSchema#string

M Gawaz

http://www.w3.org/2001/XMLSchema#string

M Seyfarth

http://www.w3.org/2001/XMLSchema#string

S Rüdiger

http://www.w3.org/2001/XMLSchema#string

P2860

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.

Epidemiology, aetiology, and prognosis of heart failure.

Thyroid disease and the heart.

Radiofrequency catheter ablation of ventricular tachycardia

Heart disease in the elderly.

Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL.

Knowledge and communication difficulties for patients with chronic heart failure: qualitative study.

P304

92-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2984729

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/HEART.85.1.92

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277506134

http://www.w3.org/2001/XMLSchema#string

P698

11119474

http://www.w3.org/2001/XMLSchema#string

P921

P932

1729582

http://www.w3.org/2001/XMLSchema#string